Shareholder News Release
Vancouver, British Columbia (FSCwire) - Brian David Skidmore issues this early warning news
release in respect of his securityholdings of Ventripoint Diagnostics Ltd. (TSXV: VPT) (the “Issuer”).
On March 2, 2017, Mr. Skidmore sold 2,000,000 common shares of the Issuer (the “Shares”) through the TSX
Venture Exchange at a price of $0.14 per share. The Shares represent approximately 6.2% of Issuer’s current issued and
outstanding common shares.
As a result of the sale of the Shares, Mr. Skidmore holds or exercises shared control or direction over a total of 2,615,347
common shares of the Issuer, representing approximately 8.1% of the current issued and outstanding shares of the Issuer and share
purchase warrants to purchase 500,000 common shares of the Issuer. Assuming the exercise in full of the share purchase
warrants, the number of common shares held by Mr. Skidmore or over which he exercised shared control or direction represents
approximately 9.7% of the current issued and outstanding common shares of the Issuer.
This news release is being disseminated pursuant to National Instrument 62-103 – The Early Warning System and
Related Take-Over Bid and Insider Reporting Issues (“NI 62-103”). A copy of the report to be filed with
Canadian securities regulators in connection with the acquisition of these securities can be obtained upon its filing under the
Issuer’s profile on the SEDAR website (www.SEDAR.com) or by contacting Ron Paton of Owen Bird
Law Corporation at 604 691 7504.
To view this press release as a PDF file, click onto the following link:
public://news_release_pdf/BrianSkidmore03032017.pdf
Source: Brian David Skidmore
To follow Brian David Skidmore on your favorite social media platform or financial websites, please click on the icons
below.
Maximum News Dissemination by FSCwire. http://www.fscwire.com
Copyright © 2017 Filing Services Canada Inc.
